Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
ACCENDRA HEALTH INC/VA/
Accendra Health is proposing a reverse stock split at a ratio between 1-for-20 and 1-for-30 to regain compliance with the NYSE's minimum closing share price requirement. The company will hold a special meeting of shareholders to vote on this proposal and a corresponding reduction in authorized shares, with the Board recommending a vote in favor.…more
ACCENDRA HEALTH INC/VA/
Accendra Health has received a notice from the NYSE for failing to maintain the minimum share price requirement of $1.00 over a 30-day period. The company has a six-month cure period to regain compliance and is considering options including a potential reverse stock split subject to shareholder approval.…more
ACCENDRA HEALTH INC/VA/
Bank of America Corp filed a Schedule 13G on October 7, 2026, reporting its beneficial ownership of Accendra Health Inc. This filing serves as an official disclosure of the firm's equity position in the company.…more
14 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Accendra Health Receives NYSE Minimum Price Notice, Considers Reverse Split…more
Accendra Health has received a notice from the NYSE for failing to maintain the minimum share price requirement. The company stated it will consider a reverse stock split if necessary to regain compliance.…more
●●●●●●●● ●●●●● ●●●●●●
Bank of America has disclosed a 10.8% stake in Accendra Health as of September 30 in a recent SEC filing. This filing indicates a significant position held by the institutional investor.…more
●●●●●●●● ●●●●● ●●●●●●
Accendra Health has named Kenneth Gardner-Smith as its next President and CEO, succeeding the retiring Edward Pesicka. Gardner-Smith is expected to assume his new role early in the fourth quarter of 2026.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.